ULTZEVIS Trademark

Trademark Overview

On Tuesday, April 1, 2014, a trademark application was filed for ULTZEVIS with the United States Patent and Trademark Office. The USPTO has given the ULTZEVIS trademark a serial number of 86239389. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 13, 2017. This trademark is owned by Merck Sharp & Dohme Corp.. The ULTZEVIS trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, antivirals
ultzevis

General Information

Serial Number86239389
Word MarkULTZEVIS
Filing DateTuesday, April 1, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 13, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 12, 2014

Trademark Statements

Goods and Servicespharmaceutical preparations, namely, antivirals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 15, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck Sharp & Dohme Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWhitehouse Station, NJ 08889
Party NameMerck Sharp & Dohme Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWhitehouse Station, NJ 08889

Trademark Events

Event DateEvent Description
Monday, November 13, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 13, 2017ABANDONMENT - NO USE STATEMENT FILED
Saturday, March 18, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 17, 2017EXTENSION 5 GRANTED
Wednesday, March 15, 2017EXTENSION 5 FILED
Wednesday, March 15, 2017TEAS EXTENSION RECEIVED
Wednesday, September 14, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 13, 2016EXTENSION 4 GRANTED
Wednesday, August 24, 2016EXTENSION 4 FILED
Wednesday, August 24, 2016TEAS EXTENSION RECEIVED
Wednesday, August 24, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, April 23, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 22, 2016EXTENSION 3 GRANTED
Monday, March 21, 2016EXTENSION 3 FILED
Monday, March 21, 2016TEAS EXTENSION RECEIVED
Friday, September 25, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 24, 2015EXTENSION 2 GRANTED
Monday, September 14, 2015EXTENSION 2 FILED
Wednesday, September 23, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 14, 2015TEAS EXTENSION RECEIVED
Thursday, March 19, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 17, 2015EXTENSION 1 GRANTED
Tuesday, March 17, 2015EXTENSION 1 FILED
Tuesday, March 17, 2015TEAS EXTENSION RECEIVED
Tuesday, October 7, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 12, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 12, 2014PUBLISHED FOR OPPOSITION
Wednesday, July 23, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 3, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 27, 2014ASSIGNED TO EXAMINER
Tuesday, April 15, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, April 4, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

ultzevis antivirals namely preparations pharmaceutical